- Home
- MGRX vs BMRA Comparison
MGRX vs BMRA Comparison
Compare MGRX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- BMRA
- Stock Information
- Founded
- MGRX 2021
- BMRA 1971
- Country
- MGRX United States
- BMRA United States
- Employees
- MGRX N/A
- BMRA N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MGRX Technology
- BMRA Health Care
- Exchange
- MGRX Nasdaq
- BMRA Nasdaq
- Market Cap
- MGRX 23.3M
- BMRA 8.2M
- IPO Year
- MGRX 2023
- BMRA N/A
- Fundamental
- Price
- MGRX $2.13
- BMRA $2.99
- Analyst Decision
- MGRX
- BMRA
- Analyst Count
- MGRX 0
- BMRA 0
- Target Price
- MGRX N/A
- BMRA N/A
- AVG Volume (30 Days)
- MGRX 198.9K
- BMRA 436.0K
- Earning Date
- MGRX 11-13-2025
- BMRA 10-14-2025
- Dividend Yield
- MGRX N/A
- BMRA N/A
- EPS Growth
- MGRX N/A
- BMRA N/A
- EPS
- MGRX N/A
- BMRA N/A
- Revenue
- MGRX $516,030.00
- BMRA $5,311,000.00
- Revenue This Year
- MGRX N/A
- BMRA N/A
- Revenue Next Year
- MGRX N/A
- BMRA N/A
- P/E Ratio
- MGRX N/A
- BMRA N/A
- Revenue Growth
- MGRX N/A
- BMRA N/A
- 52 Week Low
- MGRX $1.32
- BMRA $2.08
- 52 Week High
- MGRX $7.66
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- MGRX 54.81
- BMRA 46.09
- Support Level
- MGRX $2.07
- BMRA $2.74
- Resistance Level
- MGRX $2.48
- BMRA $3.08
- Average True Range (ATR)
- MGRX 0.28
- BMRA 0.22
- MACD
- MGRX -0.00
- BMRA 0.00
- Stochastic Oscillator
- MGRX 52.74
- BMRA 51.69
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.